Replies to post #49244 on BioAmber Inc (fka BIOAQ)

[Koan]

First of all, the shares are worthless.

The shares are currently worth about two cents. Not great, but not zero.

There is also no chance of a reverse merger without management and a board of directors to approve it. They all quit when no offers were made for the stock during the SISP phase, as they were no longer needed during the liquidation phase.

The courts granted additional powers to PwC upon the resignation of management and the board of directors. Are you certain these additional powers did not include approval of a Reverse Merger, should one arise?

And, most of all, the stock is going to be cancelled.

The argument that "the stock is going to be cancelled" cannot be used to argue "the stock is going to be cancelled", as that is circular reasoning and a logical fallacy.

This is a liquidation

Visolis and LCY Chemical are going to buy, own, and operate, making them strategic buyers. They are not liquidators. At minimum, they are strategic buyers in a "liquidation process", which makes this transaction far more nuanced than some would like.